Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KES Pharma is a Germany-based pharmaceutical company focused on the trade and export of medicines and on commercialization of topical healthcare and cosmeceutical products. Publicly available evidence indicates the company has worked with Phi-Stone AG to develop and market products based on tetrapodal zinc oxide, including an acne serum and wound-related applications. The business appears to operate primarily as a commercial-stage distributor and product marketer rather than a clinical-stage drug developer. Its known footprint is centered in Schleswig, Germany, with Dr. Kan Fu identified as a key executive contact. Overall, KES Pharma looks like a small, active healthcare company with limited disclosed pipeline depth but some differentiated product positioning through partner-sourced materials science technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KES Pharma.